Fennec Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersDurham, NC
US patents7
SAM.gov UEILA59ZMYRRTJ6
CAGE code47VF2
Incorporated inDE
- biotechnology
- improving
- lives
- experience hearing loss
- PEDMARK®
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2020–2025, 7 of them in the five years to SEP 2025.
Pharmaceuticals 7
- Therapeutic uses for sodium thiosulfate formulationsUS 12,311,026 · granted MAY 27, 2025
- Therapeutic uses for sodium thiosulfate formulationsUS 11,998,604 · granted JUN 4, 2024
- Therapeutic uses for sodium thiosulfate formulationsUS 11,964,018 · granted APR 23, 2024
- Anhydrous sodium thiosulfate and formulations thereofUS 11,617,793 · granted APR 4, 2023
- Anhydrous sodium thiosulfate and formulations thereofUS 11,510,984 · granted NOV 29, 2022
Newest 5 shown · Granted to Fennec Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Fennec Pharmaceuticals, INC. | Durham | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.